AnodyneWiki

Drospirenone

Drospirenone
Drospirenone
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass366.50 g/mol [1]
Melting point196-200 [1]
Boiling point552.2 [1]
Solubility2.25e-03 g/L [1]
Predicted LogP3.5 [1]
Structural Identifiers
[]
Molecular formulaC24H30O3
IUPAC name(1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-15,5'-oxolane]-2',7-dione
SMILESC[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C
InChIInChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1
InChIKeyMETQSPRSQINEEU-HXCATZOESA-N
CAS number67392-87-4
UNIIN295J34A25
PubChem CID68873
Pharmacokinetics[]
Elimination half-life25–33 hours
MetabolismLiver (mostly CYP450-independent (reduction, sulfation, and cleavage of lactone ring), some CYP3A4 contribution)[3][4][5]
ExcretionUrine, feces
Routes of administrationBy mouth

Drospirenone (also known as Dehydrospirorenone, Dihydrospirorenone, Drospirenona, 1,2-Dihydrospirorenone, DRSP, Drospirenonum, Zk 30595, Slynd, Zk-30595 or Zk30595).

Chemistry

 []

Drospirenone is a single defined stereoisomer.

Drospirenone matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Drospirenone and ethinyl estradiol in combination suppress the release of follicle stimulating hormone (FSH) and luteinizing hormone (LH), preventing ovulation. Other changes induced by this drug which may aid in the prevention of pregnancy include alterations in cervical mucus consistency, hindering sperm movement, and lowering the chance of embryo implantation. Drospirenone is an analog of the diuretic spironolactone, which exerts anti-mineralocorticoid activity, blocking aldosterone receptors, which increases sodium and water excretion. Studies in animals have demonstrated that drospirenone administration leads to antiandrogenic activity. This activity helps to oppose the effects of naturally occurring androgens, inhibiting the binding of dihydrotestosterone (DHT) to its receptor, and preventing androgen synthesis in the ovaries, helping to treat acne and hirsutism. Drospirenone may also decrease the level of edema in sebaceous follicle during the second half of the menstrual cycle, when acne often appears. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / inhibition / induction109
shared target36
shared target11

Medical side effects []

28 side effects listed on drug labels in (drospirenone).

  • Mental disorder
  • Breast disorder
  • Cerebral infarction
  • Depression
  • Embolism
  • Thromboembolic event
  • Erythema multiforme
  • Gastrointestinal disorder
  • Haemorrhage
  • Haemoglobin
  • Infarction
  • Breast pain
  • Myocardial infarction
  • Acute coronary syndrome
  • Nausea
  • Nervous system disorder
  • Cerebrovascular accident
  • Thrombosis
  • Uterine haemorrhage
  • Angiopathy
  • Mood swings
  • Affect lability
  • Migraine
  • Skin disorder
  • Venous occlusion
  • Vascular occlusion
  • Embolism venous
  • Loss of libido

 []

  • Australia: Drospirenone is a Schedule 4.[6]
  • Canada: Drospirenone is Prescription only.[7]
  • United States: Drospirenone is Prescription only.
  • Other: Drospirenone is a Rx-only.

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 68873, Drospirenone. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/68873
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Drospirenone. UNII: N295J34A25. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/N295J34A25
  3. Gaspard U, Endrikat J, Desager JP, Buicu C, Gerlinger C, Heithecker R. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles. Contraception. April 2004; 69(4):271–278. PMID 15033400. https://doi.org/10.1016/j.contraception.2003.11.003
  4. Bachmann G, Kopacz S. Drospirenone/ethinyl estradiol 3 mg/20 mug (24/4 day regimen): hormonal contraceptive choices - use of a fourth-generation progestin. Patient Preference and Adherence. November 2009; 3:259–264. PMID 19936169. https://doi.org/10.2147/PPA.S3901
  5. Wiesinger H, Berse M, Klein S, Gschwend S, Höchel J, Zollmann FS, Schütt B. Pharmacokinetic interaction between the CYP3A4 inhibitor ketoconazole and the hormone drospirenone in combination with ethinylestradiol or estradiol. British Journal of Clinical Pharmacology. December 2015; 80(6):1399–1410. PMID 26271371. https://doi.org/10.1111/bcp.12745
  6. Lucinda (Lupin Australia Pty Limited). Therapeutic Goods Administration (TGA). 14 January 2025. https://www.tga.gov.au/resources/prescription-medicines-registrations/lucinda-lupin-australia-pty-limited
  7. Health product highlights 2021: Annexes of products approved in 2021. Health Canada. 3 August 2022. https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/health-product-highlights-2021/appendices.html

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 19:01:31
drugspromissing (no DrugsPRO reagent data)2026-11-20 19:01:27
erowidmissing (no Erowid substance of that name)2026-11-20 19:01:27
gsrsok2026-11-20 19:01:27
hmdbmissing (hmdb.ca refused automated access to HMDB0015467)2026-11-20 19:01:27
keggok2026-11-20 19:01:29
pubchemok2026-11-20 19:01:26
redditmissing (no r/tripreports posts mention it)2026-11-20 19:01:27
siderok2026-11-20 19:01:27
structureok2026-11-20 19:01:27
wikipediaok2026-11-20 19:01:27